Cryoport Inc
$ 14.80
-1.00%
12 Aug - close price
- Market Cap 757,204,000 USD
- Current Price $ 14.80
- High / Low $ 15.02 / 14.60
- Stock P/E N/A
- Book Value 8.78
- EPS -0.82
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.02 %
- ROE -0.07 %
- 52 Week High 16.89
- 52 Week Low 7.61
About
Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.
Analyst Target Price
$19.33
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-06 | 2026-05-04 | 2026-03-03 | 2025-11-04 | 2025-08-05 | 2025-05-07 | 2025-03-04 | 2024-11-07 | 2024-08-06 | 2024-05-07 | 2024-03-12 | 2023-11-08 |
| Reported EPS | -0.2 | -0.19 | -0.1712 | -0.13 | -0.24 | -0.38 | -0.4271 | -0.21 | -0.3 | -0.42 | -1.31 | -0.41 |
| Estimated EPS | -0.2 | -0.19 | -0.2139 | -0.19 | -0.22 | -0.26 | -0.3064 | -0.22 | -0.4 | -0.37 | -0.29 | -0.29 |
| Surprise | 0 | 0 | 0.0427 | 0.06 | -0.02 | -0.12 | -0.1207 | 0.01 | 0.1 | -0.05 | -1.02 | -0.12 |
| Surprise Percentage | 0% | 0% | 19.9626% | 31.5789% | -9.0909% | -46.1538% | -39.393% | 4.5455% | 25% | -13.5135% | -351.7241% | -41.3793% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CYRX
2026-08-12 05:40:04
CryoPort Inc's President and CEO, Jerrell Shelton, sold 28,800 shares of CYRX for approximately $429,408. This transaction is part of a larger trend of insider selling at the company, with no insider purchases in the last year, suggesting insiders might view the stock as overvalued. GuruFocus's valuation model indicates the stock is "Significantly Overvalued," trading at $14.91 compared to its GF Value of $11.03, despite three gurus recently adding to their positions.
2026-08-11 23:47:59
Cryoport's President and CEO, Jerrell Shelton, sold 28,800 shares of the company's common stock for approximately $429,384 on August 11, 2026, through a pre-arranged 10b5-1 trading plan. This sale occurred as Cryoport's shares have seen significant growth, up 76% over the past year. The company recently reported strong Q2 earnings, with revenue of $49 million and a positive adjusted EBITDA of $400,000, maintaining its full-year revenue guidance.
2026-08-11 22:47:59
CryoPort CEO Jerrell Shelton sold 28,800 shares of the company's stock for over $429,000, reducing his direct holdings by 2.34%. This transaction was conducted under a pre-arranged trading plan. Despite missing earnings estimates slightly, CryoPort's revenue exceeded expectations, and analysts maintain a "Moderate Buy" rating with an average price target of $18.00.
2026-08-11 22:47:59
Cryoport, Inc. CEO Jerrell Shelton sold 28,800 shares of common stock on August 11, 2026, at a weighted average price of $14.9092 per share. This sale was conducted automatically under a Rule 10b5-1 trading plan adopted on May 11, 2026, and terminated on the day of the sale. Following this transaction, Shelton directly owns 1,201,814 shares of Cryoport common stock.
2026-08-11 20:32:19
Cryoport, Inc. has filed a Form 144 disclosing a planned sale of up to 28,800 common shares on NASDAQ, with an aggregate value of $426,816.00. The shares, originating from restricted stock units and previously exercised holdings acquired on February 29, 2012, are intended to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services. This filing indicates a neutral impact and sentiment according to Rhea-AI.
2026-08-10 07:09:32
Assenagon Asset Management S.A. reduced its stake in CryoPort, Inc. (NASDAQ:CYRX) by 23% in the second quarter, now holding 1.15 million shares valued at $18.09 million. Despite this, institutional investors collectively own 92.9% of the company, and analysts maintain a "Moderate Buy" consensus with an average price target of $18.00. CryoPort reported second-quarter revenue of $49.0 million, slightly exceeding expectations, but missed EPS estimates with a $0.20 per share loss.
